Clin Exp Reprod Med > Volume 46(2); 2019 > Article |
|
Variable | All (n = 130) | US-IUI (n = 70) | BM-IUI (n = 60) | p-value |
---|---|---|---|---|
Age (yr) | 32.68 ± 3.30 (25–40) | 32.29 ± 3.23 (25–40) | 33.15 ± 3.35 (26–40) | 0.138a) |
Body mass index (kg/m2) | 25.12 ± 4.27 (14.0–35.0) | 25.08 ± 4.25 (14.0–35.0) | 25.17 ± 4.39 (17.9–34.7) | 0.905a) |
Basal FSH (IU/L) | 6.48 ± 1.52 (1.80–9.90) | 6.51 ± 1.45 (1.80–9.90) | 6.44 ± 1.62 (2.50–9.90) | 0.810a) |
Basal LH (IU/L) | 0.983b) | |||
Median (IQR) | 4.3 (3.3–6.0) | 4.2 (3.3–6.0) | 4.3 (3.2–6.1) | |
Range | 1.4–16.7 | 1.4–14.7 | 1.5–16.7 | |
IUI indication | 0.578c) | |||
Unexplained | 54 (41.5) | 27 (38.6) | 27 (45.0) | |
Anovulation | 38 (29.2) | 21 (30.0) | 17 (28.3) | |
Tubal factor | 15 (11.5) | 11 (15.7) | 4 (6.7) | |
Mild male factor | 7 (5.4) | 2 (2.9) | 5 (8.3) | |
Endometriosis | 4 (3.1) | 2 (2.9) | 2 (3.3) | |
Tubal and mild male factor | 3 (2.3) | 2 (2.9) | 1 (1.7) | |
Anovulation and mild male factor | 4 (3.1) | 3 (4.3) | 1 (1.7) | |
Anovulation and tubal factor | 5 (3.8) | 2 (2.9) | 3 (5.0) | |
Dosage of FSH (IU) | 0.057b) | |||
Median (IQR) | 75.0 (75.0–75.0) | 75.0 (75.0–75.0) | 75.0 (75.0–75.0) | |
Range | 50.0–150.0 | 50.0–150.0 | 50.0–150.0 | |
No. of days of stimulation | 0.516b) | |||
Median (IQR) | 9.5 (8.0–12.0) | 9.0 (8.0–12.0) | 10.0 (8.0–12.0) | |
Range | 1.0–20.0 | 1.0–20.0 | 7.0–19.0 | |
Total drug dosage for stimulation (IU) | 0.151b) | |||
Median (IQR) | 750.0 (600.0–900.0) | 675.0 (600.0–900.0) | 800.0 (600.0–956.2) | |
Range | 400.0–2,250.0 | 400.0–2,250.0 | 500.0–1,900.0 | |
Endometrial lining on trigger day | 0.145b) | |||
Median (IQR) | 8.7 (7.3–10.3) | 8.4 (7.2–10.0) | 8.9 (7.4–11.0) | |
Range | 5.5–15.4 | 5.5–13.4 | 5.6–15.4 | |
No. of follicles ≥ 17 mm | 0.792c) | |||
1 | 81 (62.3) | 42 (60.0) | 39 (65.0) | |
2 | 47 (36.2) | 27 (38.6) | 20 (33.3) | |
3 | 2 (1.5) | 1 (1.4) | 1 (1.7) | |
Post-wash seminal fluid parameter | ||||
Sperm concentration (millions/mL) | 0.152b) | |||
Median (IQR) | 61.5 (25.5–98.0) | 66.0 (26.7–114.5) | 58.5 (17.7–85.5) | |
Range | 1.4–429.0 | 1.8–429.0 | 1.4–215.0 | |
Motility (A+B) (%) | 0.752b) | |||
Median (IQR) | 89.0 (76.0–93.2) | 89.0 (76.7–94.0) | 89.0 (75.2–93.0) | |
Range | 19.0–100.0 | 19.0–100.0 | 25.0–100.0 | |
Total motile sperm count (millions/mL) | 0.168b) | |||
Median (IQR) | 26.9 (8.5–43.9) | 27.5 (11.8–48.1) | 24.0 (6.4–38.5) | |
Range | 1.2–107.0 | 1.2–107.0 | 1.2–92.5 | |
Morphology (%) | 0.380b) | |||
Median (IQR) | 4.0 (2.0–5.0) | 4.0 (2.0–5.0) | 3.0 (2.0–5.0) | |
Range | 1.0–15.0 | 1.0–15.0 | 1.0–12.0 |
Values are presented as mean±standard deviation (range) or number (%) unless otherwise indicated.
IUI, intrauterine insemination; US, ultrasound; BM, blind method; FSH, follicle-stimulating hormone; LH, luteinizing hormone; IQR, interquartile range (25th–75th percentile); A, progressive linear motile sperm; B, nonlinear motile sperms.
Variable | All (n = 130) | US-IUI (n = 70) | BM-IUI (n = 60) | p-value |
---|---|---|---|---|
Clinical pregnancy | 13 (10.0) | 7 (10.0) | 6 (10.0) | > 0.995a) |
Pain VAS score | 0.175b) | |||
Median (IQR) | 2.0 (1.0–4.0) | 2.0 (1.0–4.0) | 3.0 (2.0–4.0) | |
Range | 1.0–9.0 | 1.0–9.0 | 1.0–7.0 | |
Duration (sec) | 0.886b) | |||
Median (IQR) | 40.0 (20.0–60.0) | 40.0 (24.7–60.0) | 43.5 (18.5–60.0) | |
Range | 10.0–150.0 | 10.0–150.0 | 10.0–120.0 | |
Any bleeding | 0.505a) | |||
Yes | 18 (13.8) | 11 (15.7) | 7 (11.7) | |
No | 112 (86.2) | 59 (84.3) | 53 (88.3) | |
Difficulty level | > 0.995c) | |||
Easy | 124 (95.4) | 67 (95.7) | 57 (95.0) | |
Difficult | 6 (4.6) | 3 (4.3) | 3 (5.0) |
Variable | US-IUI | BM-IUI | p-value |
---|---|---|---|
Cycle 1 | 0.389a) | ||
Number | 40 | 29 | |
Clinical pregnancy | 4 (10.0) | 1 (3.4) | |
Pain VAS score | 0.911b) | ||
Median (IQR) | 2.0 (1.2–3.0) | 2.0 (1.0–4.0) | |
Range | 1.0–8.0 | 1.0–7.0 | |
Level of difficulty | |||
Easy | 38 (95.0) | 28 (96.6) | > 0.995a) |
Difficult | 2 (5.0) | 1 (3.4) | |
Cycle 2 | |||
Number | 16 | 20 | |
Clinical pregnancy | 2 (12.5) | 3 (15.0) | > 0.995a) |
Pain VAS score | 0.109b) | ||
Median (IQR) | 2.0 (1.0–3.7) | 3.0 (2.0–4.0) | |
Range | 1.0–5.0 | 1.0–5.0 | |
Level of difficulty | 0.492a) | ||
Easy | 16 (100.0) | 18 (90.0) | |
Difficult | 0 | 2 (10.0) | |
Cycle 3 | |||
Number | 13 | 11 | |
Clinical pregnancy | 0 | 2 (18.2) | 0.199a) |
Pain VAS score | 0.745b) | ||
Median (IQR) | 2.0 (1.0–4.5) | 3.0 (2.0–4.0) | |
Range | 1.0–9.0 | 1.0–6.0 | |
Level of difficulty | > 0.995a) | ||
Easy | 12 (92.3) | 11 (100.0) | |
Difficult | 1 (7.7) | 0 |
Variable |
Clinical pregnancy |
Adjusted OR (95% CI)a) | p-value | |
---|---|---|---|---|
Yes (n = 13) | No (n = 117) | |||
Procedure | 0.558 | |||
US-IUI | 7 (53.8) | 63 (53.8) | 1.07 (0.85–1.34) | |
BM-IUI | 6 (46.2) | 54 (46.2) | 1 |
Values are presented as number (%).
OR, odds ratio; CI, confidence interval; US, ultrasound; IUI, intrauterine insemination; BM, blind method.
a) Adjusted for patient’s age, body mass index, basal follicle-stimulating hormone level, indication for IUI (anovulation and tubal factor), number of days of stimulation, total drug dosage for stimulation, endometrial lining on trigger day, post-wash sperm concentration, post-wash sperm motility, post-wash total motile sperm count, and the IUI cycle number.